UroMems is excited to announce that we have been recognized as one of Europe’s top 50 growth companies in the prestigious Tech Tour Growth50 Listing for 2025!
This recognition, voted on by Europe’s leading growth investors, highlights our high potential and our efforts to drive innovation and progress in the medical device space.